Qcii one precur 301-600 testing

Active Purchase Order Awarded Last action

Contract number
HT001423P0103
Awardee
Awarding agency
Obligated
$245,854

Award facts

Contract value 100% obligated
$245,853.58 Current and potential, with all options
Completion date 85% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00004 · Pathology reagenttesting $70,400
Exercise an Option P00003 · Rapid, evidence-based interpretation testing for every variant, every cancer type for every patient. $104,470
Other Administrative Action P00002 · Custom test and report setup service for qiagen laboratory equipment $32,000
Other Administrative Action P00001 · Pathology testing services $0
Original award $38,984

About this award

The Defense Health Agency awarded a purchase order to Qiagen, LLC for QCII ONE PRECUR 301–600 testing and pathology reagent testing, valued at $245,853.58, with an award date of May 3, 2023. No set-aside was used. Work is performed at Silver Spring, Maryland. The order is firm fixed price with an ultimate completion date of May 31, 2027.

Quick answers

Who was awarded contract HT001423P0103?

HT001423P0103 was awarded to Qiagen, LLC by Defense Health Agency (Department of Defense) on May 3, 2023.

How much is contract HT001423P0103 worth?

The government has obligated $245,854 on HT001423P0103.

Was contract HT001423P0103 competed?

The extent of competition for HT001423P0103 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award